Myeloma-Developing Regimens Using Genomics (MyDRUG)

Clinical trial NCT03732703 · COMPLETED

Trial details

NCT number: NCT03732703
Sponsor: Multiple Myeloma Research Consortium
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Relapsed Refractory Multiple Myeloma

Start date: 2019-04-01
Primary completion: 2024-12-31
Enrollment: 103

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.